vs
Side-by-side financial comparison of Angel Oak Mortgage REIT, Inc. (AOMR) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $10.9M, roughly 1.7× Angel Oak Mortgage REIT, Inc.). Angel Oak Mortgage REIT, Inc. runs the higher net margin — 103.9% vs -3.0%, a 106.9% gap on every dollar of revenue. On growth, Angel Oak Mortgage REIT, Inc. posted the faster year-over-year revenue change (10.4% vs -25.6%). Over the past eight quarters, Angel Oak Mortgage REIT, Inc.'s revenue compounded faster (12.7% CAGR vs -10.1%).
Angel Oak Mortgage REIT, Inc. is a U.S.-based real estate investment trust focused on investing in residential mortgage assets, including non-agency mortgage-backed securities, residential mortgage loans, and credit-linked real estate instruments. It serves U.S. institutional and retail investors, targeting competitive risk-adjusted returns through regular income and long-term capital growth.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
AOMR vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.9M | $18.3M |
| Net Profit | $11.3M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 103.9% | -3.0% |
| Revenue YoY | 10.4% | -25.6% |
| Net Profit YoY | 175.2% | 26.7% |
| EPS (diluted) | $0.44 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $10.9M | $18.3M | ||
| Q3 25 | $10.2M | $15.9M | ||
| Q2 25 | $9.9M | $16.1M | ||
| Q1 25 | $10.1M | $18.9M | ||
| Q4 24 | $9.9M | $24.7M | ||
| Q3 24 | $9.0M | $28.3M | ||
| Q2 24 | $9.5M | $25.8M | ||
| Q1 24 | $8.6M | $22.7M |
| Q4 25 | $11.3M | $-554.0K | ||
| Q3 25 | $11.4M | $-1.8M | ||
| Q2 25 | $767.0K | $-1.5M | ||
| Q1 25 | $20.5M | $-1.5M | ||
| Q4 24 | $-15.1M | $-756.0K | ||
| Q3 24 | $31.2M | $1.7M | ||
| Q2 24 | $-273.0K | $343.0K | ||
| Q1 24 | $12.9M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | 7.7% | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | -152.6% | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | -1.4% | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 103.9% | -3.0% | ||
| Q3 25 | 112.1% | -11.0% | ||
| Q2 25 | 7.7% | -9.3% | ||
| Q1 25 | 203.5% | -8.0% | ||
| Q4 24 | -152.6% | -3.1% | ||
| Q3 24 | 345.9% | 5.9% | ||
| Q2 24 | -2.9% | 1.3% | ||
| Q1 24 | 150.1% | -7.6% |
| Q4 25 | $0.44 | $-0.01 | ||
| Q3 25 | $0.46 | $-0.05 | ||
| Q2 25 | $0.03 | $-0.05 | ||
| Q1 25 | $0.87 | $-0.04 | ||
| Q4 24 | $-0.62 | $-0.02 | ||
| Q3 24 | $1.29 | $0.04 | ||
| Q2 24 | $-0.01 | $0.01 | ||
| Q1 24 | $0.51 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.6M | $10.7M |
| Total DebtLower is stronger | $2.3B | — |
| Stockholders' EquityBook value | $267.5M | $37.0M |
| Total Assets | $2.7B | $57.1M |
| Debt / EquityLower = less leverage | 8.51× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.6M | $10.7M | ||
| Q3 25 | $51.6M | $13.6M | ||
| Q2 25 | $40.5M | $12.5M | ||
| Q1 25 | $38.7M | $11.4M | ||
| Q4 24 | $40.8M | $15.7M | ||
| Q3 24 | $42.1M | $12.3M | ||
| Q2 24 | $44.0M | $11.9M | ||
| Q1 24 | $39.4M | $6.6M |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $267.5M | $37.0M | ||
| Q3 25 | $264.2M | $37.0M | ||
| Q2 25 | $246.4M | $30.4M | ||
| Q1 25 | $251.5M | $31.5M | ||
| Q4 24 | $239.0M | $32.6M | ||
| Q3 24 | $265.1M | $29.1M | ||
| Q2 24 | $255.8M | $23.5M | ||
| Q1 24 | $263.3M | $20.6M |
| Q4 25 | $2.7B | $57.1M | ||
| Q3 25 | $2.6B | $57.5M | ||
| Q2 25 | $2.6B | $52.6M | ||
| Q1 25 | $2.7B | $54.0M | ||
| Q4 24 | $2.3B | $59.2M | ||
| Q3 24 | $2.3B | $57.1M | ||
| Q2 24 | $2.1B | $53.0M | ||
| Q1 24 | $2.3B | $50.7M |
| Q4 25 | 8.51× | — | ||
| Q3 25 | 8.37× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-407.0M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | -35.96× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-407.0M | $2.3M | ||
| Q3 25 | $-173.4M | $-1.3M | ||
| Q2 25 | $20.6M | $1.8M | ||
| Q1 25 | $-201.7M | $-3.5M | ||
| Q4 24 | $-221.5M | $865.0K | ||
| Q3 24 | $-212.4M | $4.3M | ||
| Q2 24 | $-24.2M | $1.4M | ||
| Q1 24 | $40.2M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | -35.96× | — | ||
| Q3 25 | -15.19× | — | ||
| Q2 25 | 26.92× | — | ||
| Q1 25 | -9.83× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.81× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 3.12× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AOMR
| Nonrelated Party | $6.4M | 59% |
| Other | $4.5M | 41% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
